List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
5094-CL-0102A Phase 1, Randomized, Placebo-controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate (5094-CL-0102) English


English


5094-CL-0201Phase 2a Study of ASP5094 - A Phase 2a, Randomized, Placebo-controlled, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate - English


English


QUICK SEARCH

USEFUL LINKS